Geron Corporation Earnings
The next earnings date for Geron Corporation has not yet been scheduled.
Analyst Estimates of Geron Corporation Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Geron Corporation Earnings: Historical
| 08/05/2026 | Before Market | $-0.02 | -100.00% |
| 05/06/2026 | Before Market | $-0.00 | 75.50% |
| 02/25/2026 | --- | $-0.02 | 24.29% |
| 11/05/2025 | Before Market | $-0.03 | 0.00% |
| 08/06/2025 | Before Market | $-0.02 | 33.33% |
| 05/07/2025 | Before Market | $-0.03 | 25.00% |
| 02/26/2025 | Before Market | $-0.04 | 23.28% |
| 11/07/2024 | Before Market | $-0.04 | 50.00% |
| 08/08/2024 | Before Market | $-0.10 | 0.00% |
| 05/02/2024 | Before Market | $-0.09 | 0.00% |
More About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
“Geron Corporation Earnings” Can Refer to the Geron Corporation Earnings Date
Some people say “Geron Corporation earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Geron Corporation position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Geron Corporation Stock on the Earnings Date
If you own Geron Corporation stock (GERN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Geron Corporation might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Geron Corporation shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Geron Corporation Earnings
You can contact us any time if you would like to ask questions about Geron Corporation earnings or anything else related to the stock market.